Audrey A. Bontemps

Audrey Bontemps advises large French and multinational industrial corporations and investment funds in both domestic and cross-border M&A. She has strong experience in the structuring of international and complex transactions, as well as in the review, drafting, and negotiation of purchase agreements and related agreements.

Audrey is especially active in the pharmaceutical and chemical industries. Recent and significant deals on which Audrey had substantial involvement include: Total SA in the divestiture of its worldwide adhesives business to Arkema, and Sanofi in connection with the divestiture of its Dermik dermatology unit to Valeant Pharmaceuticals and the acquisition of a leading manufacturer of generic drugs in Colombia. She has also been involved in M&A transactions for Novartis and Solvay. [1]